Zhang Quan, Yu Kexiang, Yuan Weifeng, Xue Fangming, Sun Huaichang, Zhu Hongfei
College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Sheng Wu Gong Cheng Xue Bao. 2008 Dec;24(12):2117-21.
Following Escherichia coli lysis with alkali, cetyltrimethylammonium bromide (CTAB) was directly titrated into the supernatant. An easy and feasible technology for plasmid purification was established with the optimized proportion between the quantity of CTAB and plasmid, combined with the specific solution for DNA release and TritonX-114 for endotoxin removal. Quality detection showed that the purified plasmid was free of contamination of host RNA. The host bacterial genomic DNA, endotoxin and bacterial protein were less than 10 microg, 50 EU and 10 microg per mg plasmids, respectively. The ratio of OD260/OD280 was between 1.75-1.85. Eighty percent of the prepared plasmids were presented in the supercoiled form. The plasmid purified with this technology can satisfy all criteria stipulated by FDA. The main advantages of the technology include the avoidance of animal-derived enzymes such as ribonucleases A, Proteinase K and toxic reagents like chloroform and phenol. In addition, the technology has low cost and no pollution.
用碱裂解大肠杆菌后,将十六烷基三甲基溴化铵(CTAB)直接滴定到上清液中。通过优化CTAB与质粒的用量比例,并结合用于释放DNA的特定溶液和用于去除内毒素的TritonX-114,建立了一种简单可行的质粒纯化技术。质量检测表明,纯化后的质粒无宿主RNA污染。宿主细菌基因组DNA、内毒素和细菌蛋白的含量分别低于每毫克质粒10微克、50 EU和10微克。OD260/OD280的比值在1.75至1.85之间。所制备的质粒中有80%呈超螺旋形式。用该技术纯化的质粒可满足FDA规定的所有标准。该技术的主要优点包括避免使用动物源性酶,如核糖核酸酶A、蛋白酶K以及氯仿和苯酚等有毒试剂。此外,该技术成本低且无污染。